Literature DB >> 18212798

Clinical development of TLR agonists as adjuvants: "post-alum adjuvant" candidates may reach beyond their intended purpose.

S J Green.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18212798     DOI: 10.1038/sj.clpt.6100494

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  1 in total

1.  Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation.

Authors:  I Tamayo; J M Irache; C Mansilla; J Ochoa-Repáraz; J J Lasarte; C Gamazo
Journal:  Clin Vaccine Immunol       Date:  2010-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.